Infectious agents associated with myopathies

Current Opinion in Rheumatology

Volumn 8, Issue 6, 1996, Pages 507-513

  Ytterberg, Steven R ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE ASSOCIATION; ENTEROVIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MUMPS; POLYMYOSITIS; PRIORITY JOURNAL; RETROVIRUS; REVIEW; TOXOPLASMOSIS; VIRUS INFECTION;

ACUTE DISEASE; CHRONIC DISEASE; ENTEROVIRUS INFECTIONS; HIV INFECTIONS; HTLV-I INFECTIONS; HUMANS; MUMPS; MYOSITIS;

EID: 0030482953     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-199611000-00003     Document Type: Review

References (74)

1. Plotz PH, Dalakas M, Leff RL, Love LA, Miller FW, Cronin ME: Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis, and related disorders. Ann Intern Med 1989, 111:143-157.
2. Ytterberg SR: The relationship of infectious agents to inflammatory myositis. Rheum Dis Clin North Am 1994, 20:995-1015.
3. Hays AP, Gamboa EG: Acute viral myositis. In Myology. Edited by Engel AG, Banker BQ. New York: McGraw-Hill, 1986:1439-1466.
4. Leff RL, Love LA, Miller FW, Greenberg SJ, Klein EA, Dalakas MC, Plotz PH: Viruses in idiopathic inflammatory myopathies: absence of candidate viral genomes in muscle. Lancet 1992, 339:1192-1195.
5. Dalakas MC: Retroviruses and inflammatory myopathies in humans and primates. Baillieres Clin Neurol 1993, 2:659-691.
6. Gherardi RK: Skeletal muscle involvement in HIV-infected patients. Neuropathol Appl Neurobiol 1994, 20:232-237.
7. Snider WD, Simpson DM, Nielsen S, Gold JW, Metroka CE, Posner JB: Neurological complications of acquired immunodeficiency virus: analysis of 50 patients. Ann Neurol 1983, 14:403-418.
8. Dalakas MC, Pezeshkpour GH, Gravell M, Sever JL: Polymyositis associated with AIDS retrovirus. JAMA 1986, 256:2381-2383.
9. Illa I, Nath A, Dalakas M: Immunocytochemical and virological characteristics of HIV-associated inflammatory myopathies: similarities with seronegative polymyositis. Ann Neurol 1991, 29:474-481.
10. Chad DA, Smith TW, Blumenfeld A, Fairchild PG, Degirolami U: Human immunodeficiency virus (HIV)-associated myopathy: immunocytochemical identification of an HIV antigen (gp41) in muscle macrophages. Ann Neurol 1990, 28:579-582.
11. Leon-Monzon M, Lamperth L, Dalakas MC: Search for HIV proviral DNA and amplified sequences in the muscle biopsies of patients with HIV polymyositis. Muscle Nerve 1993, 16:408-413.
12. Dalakas MC, Illa I, Pezeshkpour GM, Laukaitis JP, Cohen B, Griffin JL: Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med 1990, 322:1098-1105.
13. Peters BS, Winer J, Landon DN, Stotter A, Pinching AJ: Mitochondrial myopathy associated with chronic zidovudine therapy in AIDS. Q J Med 1993, 86:5-15.
14. Lewis W, Dalakas MC: Mitochondrial toxicity of antiviral drugs. Nat Med 1995, 1:417-422. An excellent review of toxicity syndromes related to antiviral nucleoside analogues, including zidovudine. The authors review the clinical manifestations of these agents, the current understanding of mechanisms underlying toxicity, and a unifying hypothesis of toxicity of these drugs, explaining their effects on mitochondrial DNA.
15. Arnaudo E, Dalakas M, Shanske S, Morales CT, DiMauro S, Schon EA: Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet 1991, 337:508-510.
16. Chariot P, Monnet I, Mouchet M, Rohr M, Lefaucheur JP, Dubreuil-Lemaire ML, Chousterman M, Gherardi R: Determination of the blood lactate:pyruvate ratio as a noninvasive test for the diagnosis of zidovudine myopathy. Arthritis Rheum 1994, 37:583-586.
17. Cupler EJ, Danon MJ, Jay C, Hench K, Ropka M, Dalakas MC: Early features of zidovudine-associated myopathy: histopathological findings and clinical correlations. Acta Neuropathol 1995, 90:1-6. This report describes 13 zidovudine-treated patients who developed fatigue, myalgia, and diminished exercise tolerance but had normal muscle strength. Seven had moderate to severe mitochondrial abnormalities. The remaining six had only type II fiber atrophy on light microscopy but had mitochondrial abnormalities on electron microscopy. The observations describe the evolution of zidovudine myopathy and underscore the importance of mitochondrial abnormalities in its pathogenesis.
18. Sherman MP, Amin RM, Rodgers-Johnson PEB, Morgan OSC, Char G, Mora CA, Iannone R, Collins GH, Papsidero L, Gibbs CJ, Poiesz BJ: Identification of human T cell leukemia/lymphoma virus type I antibodies, DNA, and protein in patients with polymyositis. Arthritis Rheum 1995, 38:690-698. Eight Jamaican patients with polymyositis were studied; seven were found to be seropositive for HTLV-I. HTLV-I DNA was detected in DNA prepared from muscle biopsy specimens. By immunohistochemistry HTLV-I was shown to be mainly in mononuclear cells, but some staining of muscle fibers was seen.
19. Morgan OS, Rodgers-Johnson P, Mora C, Char G: HTLV-1 and polymyositis in Jamaica. Lancet 1989, ii:1184-1187.
20. Higuchi I, Nerenberg M, Yoshimine K, Yoshida M, Fukunaga H, Tajima K, Osame M: Failure to detect HTLV-I by in situ hybridization in the biopsied muscles of viral carriers with polymyositis. Muscle Nerve 1992, 15:43-47.
21. Nishikai M, Sato A: Human T lymphotropic virus type I and polymyositis and dermatomyositis in Japan. Arthritis Rheum 1991, 34:791-792.
22. Smadja D, Bellance R, Cabre P, Arfi S, Vernant JC: Clinical characteristics of HTLV-1 associated dermato-polymyositis: seven cases from Martinique. Acta Neurol Scand 1995, 92:206-212. This clinical description compares HTLV-I-seropositive and -seronegative patients with dermatomyositis or polymyositis in Martinique. The seropositive patients had typical IIM features. In addition, they also had neurologic findings, lacked dysphagia, and had a poor response to treatment.
23. Inose M, Higuchi I, Yoshimine K, Suehara M, Izumo S, Arimura K, Osame M: Pathological changes in skeletal muscle in HTLV-I-associated myelopathy. J Neurol Sci 1992, 110:73-78.
24. Gabbai AA, Wiley CA, Oliveira ASB, Smith R, Schmidt B, Nobrega JAM, Bordin JO, Roman GC: Skeletal muscle involvement in tropical spastic paraparesis/HTLV-1-associated myelopathy. Muscle Nerve 1994, 17:923-930.
25. Leon-Monzon M, Illa I, Dalakas MC: Polymyositis in patients infected with human T-cell leukemia virus type I: the role of the virus in the cause of the disease. Ann Neurol 1994, 36:643-649.
26. Wiley CA, Nerenberg M, Cros D, Soto-Aguilar MC: HTLV-1 polymyositis in a patient also infected with the human immunodeficiency virus. N Engl J Med 1989, 320:992-995.
27. Tangy F, Vernant JC, Coscoy L, Ossondo M, Bellance R, Zaninovic V, Cartier L, Brahic M, Ozden S: A search for human T-cell leukemia virus type I in the lesions of patients with tropical spastic paraparesis and polymyositis. Ann Neurol 1995, 38:454-460. This paper examines mechanisms involved in HTLV-I-associated polymyositis. HTLV-I proviral DNA can be found in muscle, along with viral RNA at low levels.
28. + lymphocytes in muscle but not in muscle fibers. The findings suggest that disease is due to an immunologically mediated process and not infection of muscle fibers.
29. Christensen ML, Pachman LM, Schneiderman R, Patel DC, Friedman JM: Prevalence of coxsackie B virus antibodies in patients with juvenile dermatomyositis. Arthritis Rheum 1986, 29:1365-1370.
30. Pachman LM, Litt DL, Rowley AH, Hayford JR, Caliendo J, Heller S, Ticho BS, Christensen M, Patterson B, Ytterberg SR, Pallansch M: Lack of detection of enteroviral RNA or bacterial DNA in magnetic resonance imaging-directed muscle biopsies from twenty children with active untreated juvenile dermatomyositis. Arthritis Rheum 1995, 38:1513-1518. Twenty children with untreated dermatomyositis were studied. Using appropriate positive and negative controls, myositis could not be linked to CVB, several other viruses, or bacterial infection.
31. Bowles NE, Dubowitz V, Sewry CA, Archard LC: Dermatomyositis, polymyositis, and coxsackie-B-virus infection. Lancet 1987, 1:1004-1007.
32. Yousef GE, Isenberg DA, Mowbray JF: Detection of enterovirus specific RNA sequences in muscle biopsy specimens from patients with adult onset myositis. Ann Rheum Dis 1990, 49:310-315.
33. Rosenberg NL, Rotbart HA, Abzug MJ, Ringel SP, Levin MJ: Evidence for a novel picornavirus in human dermatomyositis. Ann Neurol 1989, 26:204-209.
34. Leon-Monzon M, Dalakas MC: Absence of persistent infection with enteroviruses in muscles of patients with inflammatory myopathies. Ann Neurol 1992, 32:219-222.
35. Jongen PJ, Zoll GJ, Beaumont M, Melchers WJ, van de Putte LB, Galama JM: Polymyositis and dermatomyositis: no persistence of enterovirus or encephalomyocarditis virus RNA in muscle. Ann Rheum Dis 1993, 52:575-578.
36. Fox SA, Finklestone E, Robbins PD, Mastaglia FL, Swanson NR: Search for persistent enterovirus infection of muscle in inflammatory myopathies. J Neurol Sci 1994, 125:70-76.
37. Chou SM: Inclusion body myositis: a chronic persistent mumps myositis? Hum Pathol 1986, 17:765-767.
38. Nishino H, Engel AG, Rima BK: Inclusion body myositis: the mumps virus hypothesis. Ann Neurol 1989, 25:260-264.
39. Kallajoki M, Hyypiä T, Halonen P, Örvell C, Rima BK, Kalimo H: Inclusion body myositis and paramyxoviruses. Hum Pathol 1991, 22:29-32.
40. Fox SA, Ward BK, Robbins PD, Mastaglia FL, Swanson NR: Inclusion body myositis: investigation of the mumps virus hypothesis by polymerase chain reaction. Muscle Nerve 1996, 19:23-28.
41. Nishikai M, Miyairi M, Kosaki S: Dermatomyositis following infection with hepatitis C virus. J Rheumatol 1994, 21:1584-1585.
42. Horsmans Y, Geubel AP: Symptomatic myopathy in hepatitis C infection without interferon therapy. Lancet 1995, 345:1236.
43. Weidensaul D, Imam T, Holyst MM, King PD, McMurray RW: Polymyositis, pulmonary fibrosis, and hepatitis C. Arthritis Rheum 1995, 38:437-439.
44. Ueno Y, Kondo K, Kidokoro N, Kobashi R, Kanaji K, Matsumura T: Hepatitis C infection and polymyositis. Lancet 1995, 346:319-320. A case report of a patient with hepatitis C virus infection and polymyositis. Muscle tissue was subjected to PCR analysis to detect hepatitis C RNA. Only positive strands, the genomic RNA, and not negative strands, the replicative intermediates, could be detected, suggesting that viral replication does not occur in muscle.
45. Ueda T, Ohta K, Suzuki N, Yamagucmi M, Hiraik-horiuchi T, Watanabe J, Miyamoto T, Ito K: Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus. Am Rev Respir Dis 1992, 146:266-268.
46. Reimers CD, de Koning J, Neubert U, Preac-Mursic V, Koster JG, Muller-Felber W, Pongratz DE, Duray PH: Borrelia burgdorferi myositis: report of eight patients. J Neurol 1993, 240:278-283.
47. Muller-Felber W, Reimers CD, de Koning J, Fischer P, Pilz A, Pongratz DE: Myositis in Lyme borreliosis: an immunohistochemical study of seven patients. J Neurol Sci 1993, 118:207-212.
48. Fraser DD, Kong LI, Miller FW: Molecular detection of persistent Borrelia burgdorferi in a man with dermatomyositis. Clin Exp Rheumatol 1992, 10:387-390.
49. Horowitz HW, Sanghera K, Goldberg N, Pechman D, Kamer R, Duray P, Weinstein A: Dermatomyositis associated with Lyme disease: case report and review of Lyme myositis. Clin Infect Dis 1994, 18:166-171.
50. Hoffmann JC, Stichtenoth DO, Zeidler H, Follmann M, Brandis A, Stanek G, Wollenhaupt J: Lyme disease in a 74-year-old forest owner with symptoms of dermatomyositis. Arthritis Rheum 1995, 38:1157-1160.
51. Jeandel C, Perret C, Blain H, Jouanny P, Penin F, Laurain MC: Rhabdomyolysis with acute renal failure due to Borrelia burgdorferi. J Intern Med 1994, 235:191-192.
52. Lewkonia RM, Horne D, Dawood MR: Juvenile dermatomyositis in a child infected with human parvovirus B19. Clin Infect Dis 1995, 21:430-432.
53. Christin L, Sarosi GA: Pyomyositis in North America: case reports and review. Clin Infect Dis 1992, 15:668-677.
54. Gomez-Reino JJ, Aznar JJ, Pablos JL, Diaz-Gonzalez F, Laffon A: Nontropical pyomyositis in adults. Semin Arthritis Rheum 1994, 23:396-405.
55. McGill PE: Bacterial infections: pyomyositis. Baillieres Clin Rheumatol 1995, 9:193-200.
56. Gordon BA, Martinez S, Collins AJ: Pyomyositis: characteristics at CT and MR imaging. Radiology 1995, 197:279-286. Clinical and imaging features of 32 patients with pyomyositis are described. As is found in most series, S. aureus was the most common cause. Risk factors included intravenous drug use, steroid use, and diabetes. CT and MRI criteria for diagnosing pyomyositis were developed and tested for their ability to identify pyomyositis.
57. Fleckenstein JL, Reimers CD: Inflammatory myopathies: radiologic evaluation. Radiol Clin North Am 1996, 34:427-439.
58. Brook I: Pyomyositis in children, caused by anaerobic bacteria. J Pediatr Surg 1996, 31:394-396. Six children seen over a period of 16 years with anaerobic pyomyositis are described. All children had polymicrobial infections, some with mixed aerobic and anaerobic infections. Although the number of patients with typical aerobic pyomyositis seen during this period is not described, the report calls attention to the need to culture for anaerobic organisms when considering a diagnosis of pyomyositis.
59. Hsueh PR, Hsiue TR, Hsieh WC: Pyomyositis in intravenous drug abusers: report of a unique case and review of the literature. Clin Infect Dis 1996, 22:858-860.
60. Birkbeck D, Watson JT: Obturator internus pyomyositis: a case report. Clin Orthop 1995, 221-226.
61. Gurbani SG, Cho CT, Lee KR, Powell L: Gonococcal abscess of the obturator internal muscle: use of new diagnostic tools may eliminate the need for surgical intervention. Clin Infect Dis 1995, 20:1384-1386.
62. Haugh PJ, Levy CS, Hoff-Sullivan E, Malawer M, Kollender Y, Hoff V: Pyomyositis as the sole manifestation of disseminated gonococcal infection: case report and review. Clin Infect Dis 1996, 22:861-863.
63. Smid WM, Breukelman F, Konings JG, Daenen S: Pyomyositis in sickle cell disease: an unexpected diagnosis. Ann Hematol 1995, 70:277-278.
64. Bonomo RA, Graham R, Makley JT, Petersilge CA: Tuberculous pyomyositis: an unusual presentation of disseminated Mycobacterium tuberculosis infection. Clin Infect Dis 1995, 20:1576-1577.
65. Wilbur AC, Gorodetsky AA, Hibbeln JF, Aizenstein RI: Tuberculous myositis: CT and sonographic findings in two cases. J Clin Ultrasound 1995, 23:495-499.
66. Gabow PA, Kaehny WD, Kelleher SP: The spectrum of rhabdomyolysis. Medicine 1982, 61:141-152.
67. Poels PJE, Gabreels FJM: Rhabdomyolysis: a review of the literature. Clin Neurol Neurosurg 1993, 95:175-192.
68. Singh U, Scheld WM: Infectious etiologies of rhabdomyolysis: three case reports and review. Clin Infect Dis 1996, 22:642-649. A thorough review of infectious causes of rhabdomyolysis. Cases reported in the literature were evenly split among viral and bacterial causes. Among viruses, influenza A or B is the most common; HIV and enteroviruses are also relatively common. Among bacteria, Legionella is the most commonly reported cause. Mechanisms of rhabdomyolysis are reviewed.
69. Leebeek FWG, Baggen MGA, Mulder LJMM, Dingemans-Dumas AM: Rhabdomyolysis associated with influenza A virus infection. Neth J Med 1995, 46:189-192.
70. Guillaume MP, Van Beers D, Delforge ML, Devriendt J, Cogan E: Primary human immunodeficiency virus infection presenting as myopericarditis and rhabdomyolysis. Clin Infect Dis 1995, 21:451-452.
71. Ragnaud JM, Tahbaz A, Buisson M, Morlat P, Gin H, Coquet M, Aubertin J: Primary confection with human immunodeficiency virus and cytomegalovirus presenting as acute rhabdomyolysis. Clin Infect Dis 1995, 20:1077-1078.
72. Eustace S, McEnif N, Rastegar J, Roizental M, Costello P: Acute HIV polymyositis with complicating myoglobinuric renal failure: CT appearance. J Comput Assist Tomogr 1995, 19:321-323.
73. Chariot P, Ruet E, Authier FJ, Levy Y, Gherardi R: Acute rhabdomyolysis in patients infected by human immunodeficiency virus. Neurology 1994, 44:1692-1696.
74. Karpathios T, Kostaki M, Drakonaki S, Garoufi A, Siahanidou S, Spirou N, Theodoridis C: An epidemic with influenza B virus causing benign acute myositis in ten boys and two girls. Eur J Pediatr 1995, 154:334-336.